Skip to main content
Clinical Trials/ACTRN12605000556640
ACTRN12605000556640
Completed
Phase 3

Randomised controlled clinical trial of the efficacy and tolerability of Seroquel compared to Risperidone in the treatment of psychotic disorders among 15-18 year old adolescents.

Dr Harith Swadi0 sites60 target enrollmentSeptember 29, 2005

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr Harith Swadi
Enrollment
60
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 29, 2005
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Dr Harith Swadi

Eligibility Criteria

Inclusion Criteria

  • Provision of written informed consent. Young people under the age of 19 years admitted to the Youth Inpatient Unit YIU) with a psychotic disorder according to DSM\-IV criteria.Subjects must have a chronic or intermittent psychosis with a documented clinical diagnosis of: Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, Major Depressive Disorder with psychotic features, or Bipolar I Disorder according to the criteria of DSM IV \[18].

Exclusion Criteria

  • Patients with alcohol or substance dependence not in full remission. Previous and successful treatment with Quetiapine or Risperidone.History of non\-response to atypicals.Patients who have taken Clozapine within the previous 60 days.A positive test for pregnancy.Sexually active females who are not on a medically validated contraceptive e.g. double barrier, oral contraceptives, DepoProvera.Any clinical significant medical condition that could affect required evaluation or increase the risk of adverse affects with treatment.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 3
Randomized controlled clinical trial of the efficacy of the digital self-help program edupression.com® in mild-to-moderate unipolar depressive patientsF32.0F33.0F32.1F33.1Mild depressive episodeRecurrent depressive disorder, current episode mildModerate depressive episodeRecurrent depressive disorder, current episode moderate
DRKS00032121Medizinische Universität Wien250
Not yet recruiting
Not Applicable
To study the efficacy of Ela Churna (Elettaria Cardamomum) Pratisarana with Madhu in Vataja Mukhapakaw.s.r. Aphthous stomatitisHealth Condition 1: K121- Other forms of stomatitis
CTRI/2023/10/058931Ayurveda Mahavidyalaya Graduate Research Centre
Completed
Not Applicable
Randomized controlled trial of 4-hour versus 24-hour nasogastric rehydration in children with acute gastroenteritis and moderate dehydratioAcute viral gastroenteritis with moderate dehydrationOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon
ACTRN12610000737033Royal Children's Hospital Melbourne426
Completed
Not Applicable
Randomized, controlled trial of the clinical effect of selecrive SGLT2 blocker, ipragliflozin, and DPP-4 blocker in type 2 diabetic patients with NAFLD/NASH.- multicenter studytype 2 diabetic patients with NAFLD/NASH
JPRN-UMIN000015727Saga University55
Completed
Phase 2
Ayurvedic Management on Type II Diabetes Mellitus.Health Condition 1: E119- Type 2 diabetes mellitus without complications
CTRI/2019/02/017609Khobarkar Punam Self80